Bridgeway Capital Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$73.7K Sell
24,581
-419
-2% -$1.71K ﹤0.01% 1159
2026
Q2
$108K Buy
+25,000
New +$109K ﹤0.01% 1143
2026
Q1
– Sell
-20,000
Closed -$74.2K – 1295
2025
Q4
$74.2K Buy
+20,000
New +$172K ﹤0.01% 1156
2025
Q1
– Sell
-6,667
Closed -$111K – 1228
2024
Q4
$111K Hold
6,667
– – ﹤0.01% 1100
2024
Q3
$67.7K Buy
+6,667
New +$198K ﹤0.01% 1195

Other funds holding OM

Bridgeway Capital Management's OM Position: Q3 2026 in Review

Bridgeway Capital Management reduced its Outset Medical (OM) stake by 1.7% in Q3 2026, selling an estimated $1.71K and leaving 24,581 shares worth $73.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

Bridgeway Capital Management first reported a position in OM in Q3 2024 and has held it in 5 quarters since. The position peaked at $111K in Q4 2024. 77 funds tracked by Wall St. Rank hold OM as of Q3 2026.

  • Bridgeway Capital Management held 24,581 shares of Outset Medical worth $73.7K as of Q3 2026.
  • Bridgeway Capital Management sold 419 Outset Medical shares in Q3 2026, an estimated $1.71K.
  • Outset Medical made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q3 2026, its #1159 holding.
  • Bridgeway Capital Management first reported a position in Outset Medical in Q3 2024 and has held it in 5 quarters since.
  • Bridgeway Capital Management's Outset Medical position peaked at $111K in Q4 2024.
  • 77 funds tracked by Wall St. Rank held Outset Medical as of Q3 2026.

Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.